Kore Private Wealth’s Zymeworks ZYME Stock Holding History

Kore Private Wealth’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-500	Closed	-$18K	–	1117
2020 Q2	$18K	Hold	500	–	–	﹤0.01%	676
2020 Q1	$18K	Hold	500	–	–	﹤0.01%	610
2019 Q4	$23K	Buy	+500	New	+$18.2K	﹤0.01%	613
2019 Q2	–	Sell	-1,000	Closed	-$16K	–	806
2019 Q1	$16K	Hold	1,000	–	–	﹤0.01%	538
2018 Q4	$15K	Buy	+1,000	New	+$13.1K	﹤0.01%	526

Other funds holding ZYME

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Kore Private Wealth's ZYME Position: Q3 2020 in Review

Kore Private Wealth sold out of Zymeworks (ZYME) in Q3 2020, closing a stake of 500 shares — an estimated $18K sold.

Kore Private Wealth first reported a position in ZYME in Q4 2018 and held it in 5 quarters. The position peaked at $23K in Q4 2019. 127 funds tracked by Wall St. Rank hold ZYME as of Q3 2020.

Kore Private Wealth reported no remaining Zymeworks position as of Q3 2020 after selling out during the quarter.
Kore Private Wealth sold 500 Zymeworks shares in Q3 2020, an estimated $18K.
Kore Private Wealth first reported a position in Zymeworks in Q4 2018 and held it in 5 quarters.
Kore Private Wealth's Zymeworks position peaked at $23K in Q4 2019.
127 funds tracked by Wall St. Rank held Zymeworks as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.